Publication:
Genetic alterations in SMAD4 and K-ras in Serbian patients with endometrial carcinoma

dc.contributor.authorNikolic, Aleksandra (57194842918)
dc.contributor.authorRistanovic, Momcilo (56357953700)
dc.contributor.authorPerovic, Vladimir (57197980665)
dc.contributor.authorTrifunovic, Jovanka (33467976000)
dc.contributor.authorPerovic, Milan (36543025300)
dc.contributor.authorRadojkovic, Dragica (6602844151)
dc.date.accessioned2025-06-12T22:06:06Z
dc.date.available2025-06-12T22:06:06Z
dc.date.issued2012
dc.description.abstractObjective: This study was aimed at analyzing alterations in K-ras gene and SMAD4 gene promoter in endometrial carcinoma tissue in Serbian patients. Methods/Materials: The study has encompassed 36 patients whose endometrial cancer tissue samples and peripheral blood samples were analyzed for the presence of alterations in the K-ras gene and the SMAD4 gene promoter. The detection of K-ras codon 12 mutation was performed by polymerase chain reaction restriction fragment length polymorphism technique. Analysis of mononucleotide repeat variants at -462T(15) and -4T(12) of the SMAD4 gene promoter was performed by capillary electrophoresis analysis of DNA fragments fluorescently labeled by polymerase chain reaction. Results: Mutation in codon 12 of the K-ras gene was detected with relatively high frequency of 75.0% (27 of 36 cases). Analysis of 2 mononucleotide repeats in the SMAD4 gene promoter showed that in most cases, haplotypes -462T(15)/-4T(12) and -462T(16)/-4T(12) were present; whereas in one case, a novel haplotype -462T(15)/-4T(10) was detected. Conclusions: Findings on the role and potential significance of the K-ras codon 12 mutation and SMAD4 gene promoter variants in patients with endometrial carcinoma remain controversial, and their occurrence in this type of cancer should be further investigated. Copyright © 2012 by IGCS and ESGO.
dc.identifier.urihttps://doi.org/10.1097/IGC.0b013e31823fabab
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84858256673&doi=10.1097%2fIGC.0b013e31823fabab&partnerID=40&md5=9aa18fe55023df5b224f950f79e796dd
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/9706
dc.subjectEndometrial cancer
dc.subjectK-ras
dc.subjectSMAD4
dc.titleGenetic alterations in SMAD4 and K-ras in Serbian patients with endometrial carcinoma
dspace.entity.typePublication

Files